nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—Progesterone Congeners—Medroxyprogesterone Acetate—uterine cancer	0.407	1	CiPCiCtD
Desogestrel—PGR—uterine cancer	0.112	0.613	CbGaD
Desogestrel—ESR1—uterine cancer	0.0706	0.387	CbGaD
Desogestrel—PGR—Medroxyprogesterone Acetate—uterine cancer	0.048	0.227	CbGbCtD
Desogestrel—Norgestimate—Progesterone—uterine cancer	0.0474	0.332	CrCrCtD
Desogestrel—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0461	0.218	CbGbCtD
Desogestrel—Levonorgestrel—Progesterone—uterine cancer	0.035	0.245	CrCrCtD
Desogestrel—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0333	0.157	CbGbCtD
Desogestrel—Danazol—Progesterone—uterine cancer	0.0323	0.226	CrCrCtD
Desogestrel—PGR—Progesterone—uterine cancer	0.0318	0.15	CbGbCtD
Desogestrel—SHBG—Progesterone—uterine cancer	0.0305	0.144	CbGbCtD
Desogestrel—Norethindrone—Progesterone—uterine cancer	0.0281	0.197	CrCrCtD
Desogestrel—ESR1—Progesterone—uterine cancer	0.0221	0.104	CbGbCtD
Desogestrel—PGR—corpus luteum—uterine cancer	0.00423	0.236	CbGeAlD
Desogestrel—SHBG—semen—uterine cancer	0.0022	0.123	CbGeAlD
Desogestrel—Chloasma—Progesterone—uterine cancer	0.00195	0.0661	CcSEcCtD
Desogestrel—Chloasma—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.0599	CcSEcCtD
Desogestrel—PGR—oviduct—uterine cancer	0.00145	0.0811	CbGeAlD
Desogestrel—Breast discharge—Progesterone—uterine cancer	0.00138	0.0469	CcSEcCtD
Desogestrel—Breast discharge—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.0425	CcSEcCtD
Desogestrel—ESR1—oviduct—uterine cancer	0.00114	0.0634	CbGeAlD
Desogestrel—Breast tenderness—Progesterone—uterine cancer	0.00104	0.0352	CcSEcCtD
Desogestrel—PGR—artery—uterine cancer	0.000962	0.0537	CbGeAlD
Desogestrel—Breast tenderness—Medroxyprogesterone Acetate—uterine cancer	0.000939	0.0319	CcSEcCtD
Desogestrel—Breast cancer—Progesterone—uterine cancer	0.000926	0.0314	CcSEcCtD
Desogestrel—Breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.000839	0.0285	CcSEcCtD
Desogestrel—Erythema nodosum—Progesterone—uterine cancer	0.000781	0.0265	CcSEcCtD
Desogestrel—Erythema nodosum—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.024	CcSEcCtD
Desogestrel—Hirsutism—Progesterone—uterine cancer	0.000581	0.0197	CcSEcCtD
Desogestrel—Vaginal discharge—Progesterone—uterine cancer	0.000555	0.0188	CcSEcCtD
Desogestrel—Hirsutism—Medroxyprogesterone Acetate—uterine cancer	0.000527	0.0179	CcSEcCtD
Desogestrel—Breast enlargement—Progesterone—uterine cancer	0.000521	0.0177	CcSEcCtD
Desogestrel—Libido increased—Medroxyprogesterone Acetate—uterine cancer	0.000503	0.0171	CcSEcCtD
Desogestrel—Vaginal discharge—Medroxyprogesterone Acetate—uterine cancer	0.000503	0.0171	CcSEcCtD
Desogestrel—PGR—myometrium—uterine cancer	0.000465	0.0259	CbGeAlD
Desogestrel—Breast pain—Progesterone—uterine cancer	0.000387	0.0131	CcSEcCtD
Desogestrel—PGR—epithelium—uterine cancer	0.000365	0.0204	CbGeAlD
Desogestrel—ESR1—myometrium—uterine cancer	0.000363	0.0203	CbGeAlD
Desogestrel—SHBG—endometrium—uterine cancer	0.000363	0.0203	CbGeAlD
Desogestrel—PGR—uterine cervix—uterine cancer	0.000362	0.0202	CbGeAlD
Desogestrel—PGR—smooth muscle tissue—uterine cancer	0.000351	0.0196	CbGeAlD
Desogestrel—Breast pain—Medroxyprogesterone Acetate—uterine cancer	0.000351	0.0119	CcSEcCtD
Desogestrel—PGR—decidua—uterine cancer	0.000344	0.0192	CbGeAlD
Desogestrel—SHBG—uterus—uterine cancer	0.000335	0.0187	CbGeAlD
Desogestrel—PGR—endometrium—uterine cancer	0.000327	0.0183	CbGeAlD
Desogestrel—Fluid retention—Progesterone—uterine cancer	0.000321	0.0109	CcSEcCtD
Desogestrel—Neoplasm—Progesterone—uterine cancer	0.000305	0.0104	CcSEcCtD
Desogestrel—PGR—uterus—uterine cancer	0.000301	0.0168	CbGeAlD
Desogestrel—SHBG—female reproductive system—uterine cancer	0.000301	0.0168	CbGeAlD
Desogestrel—Fluid retention—Medroxyprogesterone Acetate—uterine cancer	0.000291	0.00986	CcSEcCtD
Desogestrel—ESR1—epithelium—uterine cancer	0.000285	0.0159	CbGeAlD
Desogestrel—ESR1—uterine cervix—uterine cancer	0.000283	0.0158	CbGeAlD
Desogestrel—Neoplasm—Medroxyprogesterone Acetate—uterine cancer	0.000277	0.00939	CcSEcCtD
Desogestrel—ESR1—smooth muscle tissue—uterine cancer	0.000275	0.0153	CbGeAlD
Desogestrel—SHBG—female gonad—uterine cancer	0.000274	0.0153	CbGeAlD
Desogestrel—SHBG—vagina—uterine cancer	0.000272	0.0152	CbGeAlD
Desogestrel—PGR—female reproductive system—uterine cancer	0.000271	0.0151	CbGeAlD
Desogestrel—ESR1—decidua—uterine cancer	0.000269	0.015	CbGeAlD
Desogestrel—ESR1—renal system—uterine cancer	0.000265	0.0148	CbGeAlD
Desogestrel—Libido decreased—Progesterone—uterine cancer	0.000264	0.00897	CcSEcCtD
Desogestrel—ESR1—endometrium—uterine cancer	0.000256	0.0143	CbGeAlD
Desogestrel—PGR—Ovarian Infertility Genes—MLH1—uterine cancer	0.000249	0.0379	CbGpPWpGaD
Desogestrel—PGR—female gonad—uterine cancer	0.000246	0.0138	CbGeAlD
Desogestrel—PGR—vagina—uterine cancer	0.000245	0.0137	CbGeAlD
Desogestrel—Disturbance in sexual arousal—Progesterone—uterine cancer	0.000243	0.00825	CcSEcCtD
Desogestrel—Migraine—Progesterone—uterine cancer	0.000241	0.00819	CcSEcCtD
Desogestrel—Affect lability—Progesterone—uterine cancer	0.000241	0.00819	CcSEcCtD
Desogestrel—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00813	CcSEcCtD
Desogestrel—ESR1—uterus—uterine cancer	0.000236	0.0132	CbGeAlD
Desogestrel—Mood swings—Progesterone—uterine cancer	0.000232	0.00788	CcSEcCtD
Desogestrel—Erythema nodosum—Epirubicin—uterine cancer	0.000224	0.0076	CcSEcCtD
Desogestrel—Breast disorder—Progesterone—uterine cancer	0.000222	0.00752	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.00022	0.00748	CcSEcCtD
Desogestrel—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00742	CcSEcCtD
Desogestrel—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00742	CcSEcCtD
Desogestrel—ESR1—female reproductive system—uterine cancer	0.000212	0.0118	CbGeAlD
Desogestrel—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.000211	0.00714	CcSEcCtD
Desogestrel—PGR—Ovarian Infertility Genes—ESR2—uterine cancer	0.000208	0.0317	CbGpPWpGaD
Desogestrel—Erythema nodosum—Doxorubicin—uterine cancer	0.000207	0.00703	CcSEcCtD
Desogestrel—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.000201	0.00681	CcSEcCtD
Desogestrel—Weight increased—Progesterone—uterine cancer	0.000193	0.00654	CcSEcCtD
Desogestrel—ESR1—female gonad—uterine cancer	0.000193	0.0108	CbGeAlD
Desogestrel—Weight decreased—Progesterone—uterine cancer	0.000192	0.0065	CcSEcCtD
Desogestrel—ESR1—vagina—uterine cancer	0.000192	0.0107	CbGeAlD
Desogestrel—PGR—Ovarian Infertility Genes—CYP19A1—uterine cancer	0.000189	0.0287	CbGpPWpGaD
Desogestrel—PGR—Nuclear Receptors—ESR2—uterine cancer	0.000181	0.0276	CbGpPWpGaD
Desogestrel—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.000175	0.00593	CcSEcCtD
Desogestrel—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.000174	0.00589	CcSEcCtD
Desogestrel—Erythema multiforme—Progesterone—uterine cancer	0.00016	0.00544	CcSEcCtD
Desogestrel—Vaginal discharge—Epirubicin—uterine cancer	0.000159	0.0054	CcSEcCtD
Desogestrel—Eye disorder—Progesterone—uterine cancer	0.000159	0.00538	CcSEcCtD
Desogestrel—PGR—lymph node—uterine cancer	0.000158	0.00885	CbGeAlD
Desogestrel—PGR—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000154	0.0235	CbGpPWpGaD
Desogestrel—Immune system disorder—Progesterone—uterine cancer	0.000153	0.0052	CcSEcCtD
Desogestrel—Norelgestromin—PGR—uterine cancer	0.000153	0.0887	CrCbGaD
Desogestrel—Allylestrenol—PGR—uterine cancer	0.000153	0.0887	CrCbGaD
Desogestrel—Alopecia—Progesterone—uterine cancer	0.00015	0.00508	CcSEcCtD
Desogestrel—Mental disorder—Progesterone—uterine cancer	0.000149	0.00504	CcSEcCtD
Desogestrel—Malnutrition—Progesterone—uterine cancer	0.000148	0.00501	CcSEcCtD
Desogestrel—Vaginal discharge—Doxorubicin—uterine cancer	0.000147	0.005	CcSEcCtD
Desogestrel—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000145	0.00493	CcSEcCtD
Desogestrel—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.00487	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000143	0.0218	CbGpPWpGaD
Desogestrel—SHBG—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	0.00014	0.0214	CbGpPWpGaD
Desogestrel—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00471	CcSEcCtD
Desogestrel—Norgestimate—PGR—uterine cancer	0.000137	0.0798	CrCbGaD
Desogestrel—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.00461	CcSEcCtD
Desogestrel—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000135	0.00457	CcSEcCtD
Desogestrel—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000134	0.00454	CcSEcCtD
Desogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—uterine cancer	0.00013	0.0198	CbGpPWpGaD
Desogestrel—Hypertension—Progesterone—uterine cancer	0.000128	0.00432	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000127	0.0194	CbGpPWpGaD
Desogestrel—Danazol—CCL2—uterine cancer	0.000126	0.0731	CrCbGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000125	0.00423	CcSEcCtD
Desogestrel—Quinestrol—ESR1—uterine cancer	0.000124	0.072	CrCbGaD
Desogestrel—ESR1—lymph node—uterine cancer	0.000124	0.00692	CbGeAlD
Desogestrel—ESR1—Nuclear Receptors—PGR—uterine cancer	0.000121	0.0184	CbGpPWpGaD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	0.000119	0.0182	CbGpPWpGaD
Desogestrel—Etonogestrel—PGR—uterine cancer	0.000119	0.0691	CrCbGaD
Desogestrel—Nervous system disorder—Progesterone—uterine cancer	0.000118	0.00401	CcSEcCtD
Desogestrel—ESR1—Nuclear signaling by ERBB4—PGR—uterine cancer	0.000118	0.018	CbGpPWpGaD
Desogestrel—Skin disorder—Progesterone—uterine cancer	0.000117	0.00397	CcSEcCtD
Desogestrel—ESR1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.000115	0.0175	CbGpPWpGaD
Desogestrel—SHBG—Nongenotropic Androgen signaling—AKT1—uterine cancer	0.000115	0.0175	CbGpPWpGaD
Desogestrel—Erythema multiforme—Dactinomycin—uterine cancer	0.000113	0.00385	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000113	0.00384	CcSEcCtD
Desogestrel—Breast pain—Epirubicin—uterine cancer	0.000111	0.00377	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—ESR1—uterine cancer	0.00011	0.0167	CbGpPWpGaD
Desogestrel—PGR—Nuclear signaling by ERBB4—ESR1—uterine cancer	0.000108	0.0164	CbGpPWpGaD
Desogestrel—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000107	0.00363	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—ESR2—uterine cancer	0.000106	0.0162	CbGpPWpGaD
Desogestrel—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000106	0.0036	CcSEcCtD
Desogestrel—Alopecia—Dactinomycin—uterine cancer	0.000106	0.00359	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—YWHAE—uterine cancer	0.000104	0.0159	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Progesterone—uterine cancer	0.000104	0.00353	CcSEcCtD
Desogestrel—Breast pain—Doxorubicin—uterine cancer	0.000103	0.00348	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—ESR2—uterine cancer	0.0001	0.0152	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Progesterone—uterine cancer	9.86e-05	0.00334	CcSEcCtD
Desogestrel—Allylestrenol—ESR1—uterine cancer	9.64e-05	0.056	CrCbGaD
Desogestrel—Urticaria—Progesterone—uterine cancer	9.58e-05	0.00325	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—PGR—uterine cancer	9.54e-05	0.0145	CbGpPWpGaD
Desogestrel—Abdominal pain—Progesterone—uterine cancer	9.53e-05	0.00323	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	9.43e-05	0.0032	CcSEcCtD
Desogestrel—Mestranol—ESR1—uterine cancer	9.39e-05	0.0545	CrCbGaD
Desogestrel—Fluid retention—Epirubicin—uterine cancer	9.2e-05	0.00312	CcSEcCtD
Desogestrel—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	8.93e-05	0.00303	CcSEcCtD
Desogestrel—Hypersensitivity—Progesterone—uterine cancer	8.88e-05	0.00301	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	8.79e-05	0.0134	CbGpPWpGaD
Desogestrel—Neoplasm—Epirubicin—uterine cancer	8.76e-05	0.00297	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—STK11—uterine cancer	8.74e-05	0.0133	CbGpPWpGaD
Desogestrel—Norgestimate—ESR1—uterine cancer	8.68e-05	0.0504	CrCbGaD
Desogestrel—Urticaria—Medroxyprogesterone Acetate—uterine cancer	8.68e-05	0.00294	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	8.68e-05	0.0132	CbGpPWpGaD
Desogestrel—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	8.63e-05	0.00293	CcSEcCtD
Desogestrel—PGR—Ovarian Infertility Genes—CDKN1B—uterine cancer	8.56e-05	0.0131	CbGpPWpGaD
Desogestrel—Fluid retention—Doxorubicin—uterine cancer	8.51e-05	0.00289	CcSEcCtD
Desogestrel—Levonorgestrel—PGR—uterine cancer	8.42e-05	0.0489	CrCbGaD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	8.4e-05	0.0128	CbGpPWpGaD
Desogestrel—Diarrhoea—Progesterone—uterine cancer	8.25e-05	0.0028	CcSEcCtD
Desogestrel—Erythema multiforme—Etoposide—uterine cancer	8.21e-05	0.00278	CcSEcCtD
Desogestrel—Eye disorder—Etoposide—uterine cancer	8.11e-05	0.00275	CcSEcCtD
Desogestrel—Neoplasm—Doxorubicin—uterine cancer	8.1e-05	0.00275	CcSEcCtD
Desogestrel—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	8.05e-05	0.00273	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	7.95e-05	0.0121	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	7.9e-05	0.012	CbGpPWpGaD
Desogestrel—Immune system disorder—Etoposide—uterine cancer	7.84e-05	0.00266	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—IRF1—uterine cancer	7.73e-05	0.0118	CbGpPWpGaD
Desogestrel—Alopecia—Etoposide—uterine cancer	7.67e-05	0.0026	CcSEcCtD
Desogestrel—Danazol—PGR—uterine cancer	7.67e-05	0.0445	CrCbGaD
Desogestrel—Vomiting—Progesterone—uterine cancer	7.66e-05	0.0026	CcSEcCtD
Desogestrel—Rash—Progesterone—uterine cancer	7.6e-05	0.00258	CcSEcCtD
Desogestrel—Dermatitis—Progesterone—uterine cancer	7.59e-05	0.00258	CcSEcCtD
Desogestrel—Headache—Progesterone—uterine cancer	7.55e-05	0.00256	CcSEcCtD
Desogestrel—Etonogestrel—ESR1—uterine cancer	7.51e-05	0.0436	CrCbGaD
Desogestrel—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	7.47e-05	0.00253	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR2—uterine cancer	7.27e-05	0.0422	CrCbGaD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR1—uterine cancer	7.23e-05	0.011	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—YWHAE—uterine cancer	7.23e-05	0.011	CbGpPWpGaD
Desogestrel—Nausea—Progesterone—uterine cancer	7.16e-05	0.00243	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	7e-05	0.0107	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Dactinomycin—uterine cancer	6.97e-05	0.00236	CcSEcCtD
Desogestrel—Vomiting—Medroxyprogesterone Acetate—uterine cancer	6.94e-05	0.00236	CcSEcCtD
Desogestrel—Affect lability—Epirubicin—uterine cancer	6.92e-05	0.00235	CcSEcCtD
Desogestrel—Migraine—Epirubicin—uterine cancer	6.92e-05	0.00235	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—BIRC5—uterine cancer	6.89e-05	0.0105	CbGpPWpGaD
Desogestrel—Rash—Medroxyprogesterone Acetate—uterine cancer	6.89e-05	0.00234	CcSEcCtD
Desogestrel—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	6.88e-05	0.00233	CcSEcCtD
Desogestrel—Headache—Medroxyprogesterone Acetate—uterine cancer	6.84e-05	0.00232	CcSEcCtD
Desogestrel—Norethindrone—PGR—uterine cancer	6.82e-05	0.0396	CrCbGaD
Desogestrel—Abdominal pain—Dactinomycin—uterine cancer	6.74e-05	0.00228	CcSEcCtD
Desogestrel—Mood swings—Epirubicin—uterine cancer	6.66e-05	0.00226	CcSEcCtD
Desogestrel—Hypertension—Etoposide—uterine cancer	6.52e-05	0.00221	CcSEcCtD
Desogestrel—Nausea—Medroxyprogesterone Acetate—uterine cancer	6.49e-05	0.0022	CcSEcCtD
Desogestrel—Migraine—Doxorubicin—uterine cancer	6.41e-05	0.00217	CcSEcCtD
Desogestrel—Affect lability—Doxorubicin—uterine cancer	6.41e-05	0.00217	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	6.39e-05	0.00217	CcSEcCtD
Desogestrel—Breast disorder—Epirubicin—uterine cancer	6.36e-05	0.00216	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—SOCS3—uterine cancer	6.35e-05	0.00968	CbGpPWpGaD
Desogestrel—Hypersensitivity—Dactinomycin—uterine cancer	6.28e-05	0.00213	CcSEcCtD
Desogestrel—Mood swings—Doxorubicin—uterine cancer	6.16e-05	0.00209	CcSEcCtD
Desogestrel—Skin disorder—Etoposide—uterine cancer	5.99e-05	0.00203	CcSEcCtD
Desogestrel—Breast disorder—Doxorubicin—uterine cancer	5.88e-05	0.00199	CcSEcCtD
Desogestrel—Diarrhoea—Dactinomycin—uterine cancer	5.83e-05	0.00198	CcSEcCtD
Desogestrel—Levonorgestrel—CYP19A1—uterine cancer	5.77e-05	0.0335	CrCbGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	5.77e-05	0.0088	CbGpPWpGaD
Desogestrel—Weight increased—Epirubicin—uterine cancer	5.53e-05	0.00188	CcSEcCtD
Desogestrel—Weight decreased—Epirubicin—uterine cancer	5.5e-05	0.00186	CcSEcCtD
Desogestrel—Vomiting—Dactinomycin—uterine cancer	5.42e-05	0.00184	CcSEcCtD
Desogestrel—Rash—Dactinomycin—uterine cancer	5.37e-05	0.00182	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Etoposide—uterine cancer	5.32e-05	0.00181	CcSEcCtD
Desogestrel—Levonorgestrel—ESR1—uterine cancer	5.31e-05	0.0309	CrCbGaD
Desogestrel—Danazol—CYP19A1—uterine cancer	5.26e-05	0.0305	CrCbGaD
Desogestrel—ESR1—Leptin signaling pathway—SOCS3—uterine cancer	5.24e-05	0.00799	CbGpPWpGaD
Desogestrel—Weight increased—Doxorubicin—uterine cancer	5.12e-05	0.00174	CcSEcCtD
Desogestrel—Weight decreased—Doxorubicin—uterine cancer	5.09e-05	0.00173	CcSEcCtD
Desogestrel—Nausea—Dactinomycin—uterine cancer	5.06e-05	0.00172	CcSEcCtD
Desogestrel—Gastrointestinal pain—Etoposide—uterine cancer	5.04e-05	0.00171	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—SMAD3—uterine cancer	4.96e-05	0.00756	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	4.91e-05	0.00748	CbGpPWpGaD
Desogestrel—Urticaria—Etoposide—uterine cancer	4.9e-05	0.00166	CcSEcCtD
Desogestrel—Abdominal pain—Etoposide—uterine cancer	4.87e-05	0.00165	CcSEcCtD
Desogestrel—Danazol—ESR1—uterine cancer	4.84e-05	0.0281	CrCbGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	4.72e-05	0.0072	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	4.68e-05	0.00714	CbGpPWpGaD
Desogestrel—Erythema multiforme—Epirubicin—uterine cancer	4.6e-05	0.00156	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—CDKN2A—uterine cancer	4.56e-05	0.00696	CbGpPWpGaD
Desogestrel—Eye disorder—Epirubicin—uterine cancer	4.55e-05	0.00154	CcSEcCtD
Desogestrel—Hypersensitivity—Etoposide—uterine cancer	4.54e-05	0.00154	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR1—uterine cancer	4.48e-05	0.026	CrCbGaD
Desogestrel—Immune system disorder—Epirubicin—uterine cancer	4.39e-05	0.00149	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	4.32e-05	0.00658	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	4.31e-05	0.00657	CbGpPWpGaD
Desogestrel—Alopecia—Epirubicin—uterine cancer	4.3e-05	0.00146	CcSEcCtD
Desogestrel—Mental disorder—Epirubicin—uterine cancer	4.26e-05	0.00145	CcSEcCtD
Desogestrel—Erythema multiforme—Doxorubicin—uterine cancer	4.26e-05	0.00144	CcSEcCtD
Desogestrel—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	4.25e-05	0.00648	CbGpPWpGaD
Desogestrel—Malnutrition—Epirubicin—uterine cancer	4.24e-05	0.00144	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—FGFR2—uterine cancer	4.23e-05	0.00645	CbGpPWpGaD
Desogestrel—Diarrhoea—Etoposide—uterine cancer	4.22e-05	0.00143	CcSEcCtD
Desogestrel—Eye disorder—Doxorubicin—uterine cancer	4.21e-05	0.00143	CcSEcCtD
Desogestrel—Immune system disorder—Doxorubicin—uterine cancer	4.07e-05	0.00138	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—PGR—uterine cancer	3.98e-05	0.00607	CbGpPWpGaD
Desogestrel—Alopecia—Doxorubicin—uterine cancer	3.98e-05	0.00135	CcSEcCtD
Desogestrel—Mental disorder—Doxorubicin—uterine cancer	3.94e-05	0.00134	CcSEcCtD
Desogestrel—Vomiting—Etoposide—uterine cancer	3.92e-05	0.00133	CcSEcCtD
Desogestrel—Malnutrition—Doxorubicin—uterine cancer	3.92e-05	0.00133	CcSEcCtD
Desogestrel—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	3.89e-05	0.00594	CbGpPWpGaD
Desogestrel—Rash—Etoposide—uterine cancer	3.89e-05	0.00132	CcSEcCtD
Desogestrel—Dermatitis—Etoposide—uterine cancer	3.88e-05	0.00132	CcSEcCtD
Desogestrel—Headache—Etoposide—uterine cancer	3.86e-05	0.00131	CcSEcCtD
Desogestrel—PGR—Gene Expression—PHF1—uterine cancer	3.81e-05	0.0058	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.76e-05	0.00573	CbGpPWpGaD
Desogestrel—Nausea—Etoposide—uterine cancer	3.66e-05	0.00124	CcSEcCtD
Desogestrel—Hypertension—Epirubicin—uterine cancer	3.66e-05	0.00124	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—ESR1—uterine cancer	3.62e-05	0.00552	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	3.58e-05	0.00121	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	3.55e-05	0.00541	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	3.48e-05	0.0053	CbGpPWpGaD
Desogestrel—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	3.47e-05	0.00529	CbGpPWpGaD
Desogestrel—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	3.42e-05	0.00521	CbGpPWpGaD
Desogestrel—Nervous system disorder—Epirubicin—uterine cancer	3.39e-05	0.00115	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	3.39e-05	0.00516	CbGpPWpGaD
Desogestrel—Hypertension—Doxorubicin—uterine cancer	3.38e-05	0.00115	CcSEcCtD
Desogestrel—Skin disorder—Epirubicin—uterine cancer	3.36e-05	0.00114	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	3.31e-05	0.00112	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.3e-05	0.00503	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—CHD4—uterine cancer	3.24e-05	0.00494	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	3.2e-05	0.00488	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	3.2e-05	0.00488	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	3.15e-05	0.00481	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.15e-05	0.0048	CbGpPWpGaD
Desogestrel—Nervous system disorder—Doxorubicin—uterine cancer	3.14e-05	0.00106	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.13e-05	0.00477	CbGpPWpGaD
Desogestrel—Skin disorder—Doxorubicin—uterine cancer	3.11e-05	0.00105	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.09e-05	0.00471	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	3.03e-05	0.00462	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Epirubicin—uterine cancer	2.98e-05	0.00101	CcSEcCtD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	2.94e-05	0.00448	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.92e-05	0.00445	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	2.91e-05	0.00444	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Epirubicin—uterine cancer	2.83e-05	0.000959	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.76e-05	0.000936	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	2.75e-05	0.00419	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	2.75e-05	0.00419	CbGpPWpGaD
Desogestrel—Urticaria—Epirubicin—uterine cancer	2.75e-05	0.000931	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	2.74e-05	0.00418	CbGpPWpGaD
Desogestrel—Abdominal pain—Epirubicin—uterine cancer	2.73e-05	0.000927	CcSEcCtD
Desogestrel—PGR—Gene Expression—SUZ12—uterine cancer	2.71e-05	0.00414	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	2.7e-05	0.00412	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	2.69e-05	0.0041	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	2.68e-05	0.00408	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—ERBB2—uterine cancer	2.66e-05	0.00405	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.66e-05	0.00405	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.65e-05	0.00404	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Doxorubicin—uterine cancer	2.62e-05	0.000887	CcSEcCtD
Desogestrel—Hypersensitivity—Epirubicin—uterine cancer	2.55e-05	0.000864	CcSEcCtD
Desogestrel—Urticaria—Doxorubicin—uterine cancer	2.54e-05	0.000862	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	2.54e-05	0.00387	CbGpPWpGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	2.53e-05	0.00386	CbGpPWpGaD
Desogestrel—Abdominal pain—Doxorubicin—uterine cancer	2.53e-05	0.000857	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—TP53—uterine cancer	2.49e-05	0.0038	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	2.48e-05	0.00379	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	2.48e-05	0.00378	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	2.47e-05	0.00377	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ESR2—uterine cancer	2.47e-05	0.00377	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—CDKN1B—uterine cancer	2.46e-05	0.00375	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.38e-05	0.00362	CbGpPWpGaD
Desogestrel—Diarrhoea—Epirubicin—uterine cancer	2.37e-05	0.000802	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—EP300—uterine cancer	2.36e-05	0.0036	CbGpPWpGaD
Desogestrel—Hypersensitivity—Doxorubicin—uterine cancer	2.36e-05	0.000799	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—PTEN—uterine cancer	2.27e-05	0.00346	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.26e-05	0.00344	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PHF1—uterine cancer	2.23e-05	0.00341	CbGpPWpGaD
Desogestrel—Vomiting—Epirubicin—uterine cancer	2.2e-05	0.000745	CcSEcCtD
Desogestrel—Diarrhoea—Doxorubicin—uterine cancer	2.19e-05	0.000742	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	2.19e-05	0.00333	CbGpPWpGaD
Desogestrel—Rash—Epirubicin—uterine cancer	2.18e-05	0.000739	CcSEcCtD
Desogestrel—Dermatitis—Epirubicin—uterine cancer	2.18e-05	0.000738	CcSEcCtD
Desogestrel—Headache—Epirubicin—uterine cancer	2.17e-05	0.000734	CcSEcCtD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	2.1e-05	0.0032	CbGpPWpGaD
Desogestrel—Nausea—Epirubicin—uterine cancer	2.05e-05	0.000696	CcSEcCtD
Desogestrel—Vomiting—Doxorubicin—uterine cancer	2.03e-05	0.00069	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—NRAS—uterine cancer	2.02e-05	0.00308	CbGpPWpGaD
Desogestrel—Rash—Doxorubicin—uterine cancer	2.02e-05	0.000684	CcSEcCtD
Desogestrel—Dermatitis—Doxorubicin—uterine cancer	2.01e-05	0.000683	CcSEcCtD
Desogestrel—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	2.01e-05	0.00307	CbGpPWpGaD
Desogestrel—Headache—Doxorubicin—uterine cancer	2e-05	0.000679	CcSEcCtD
Desogestrel—ESR1—Gene Expression—CHD4—uterine cancer	1.9e-05	0.0029	CbGpPWpGaD
Desogestrel—Nausea—Doxorubicin—uterine cancer	1.9e-05	0.000644	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	1.86e-05	0.00283	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	1.84e-05	0.0028	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—KRAS—uterine cancer	1.74e-05	0.00265	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKR1B10—uterine cancer	1.72e-05	0.00262	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—TP53—uterine cancer	1.69e-05	0.00257	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—PGR—uterine cancer	1.65e-05	0.00251	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	1.6e-05	0.00244	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SUZ12—uterine cancer	1.59e-05	0.00243	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	1.56e-05	0.00238	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—HRAS—uterine cancer	1.53e-05	0.00233	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ESR1—uterine cancer	1.5e-05	0.00228	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—HRAS—uterine cancer	1.48e-05	0.00226	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—AKT1—uterine cancer	1.46e-05	0.00222	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	1.45e-05	0.00221	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	1.44e-05	0.0022	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RNF43—uterine cancer	1.42e-05	0.00217	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.37e-05	0.00209	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—AKT1—uterine cancer	1.35e-05	0.00206	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.34e-05	0.00204	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PTEN—uterine cancer	1.33e-05	0.00203	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—AKT1—uterine cancer	1.31e-05	0.00199	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—INHBA—uterine cancer	1.3e-05	0.00198	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.3e-05	0.00198	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—EZH2—uterine cancer	1.28e-05	0.00196	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.28e-05	0.00194	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.27e-05	0.00193	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.21e-05	0.00184	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.2e-05	0.00183	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR2—uterine cancer	1.19e-05	0.00181	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—NRAS—uterine cancer	1.19e-05	0.00181	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.18e-05	0.0018	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKR1C1—uterine cancer	1.17e-05	0.00179	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.14e-05	0.00173	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.11e-05	0.00169	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	1.08e-05	0.00164	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.06e-05	0.00161	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.03e-05	0.00157	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—KRAS—uterine cancer	1.02e-05	0.00156	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKR1B10—uterine cancer	1.01e-05	0.00154	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1e-05	0.00153	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—CDKN2B—uterine cancer	9.68e-06	0.00148	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	9.38e-06	0.00143	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	9.13e-06	0.00139	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKR1C3—uterine cancer	9.01e-06	0.00137	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—SMAD3—uterine cancer	8.84e-06	0.00135	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—HRAS—uterine cancer	8.68e-06	0.00132	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	8.51e-06	0.0013	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—YWHAE—uterine cancer	8.38e-06	0.00128	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RNF43—uterine cancer	8.35e-06	0.00127	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FBXW7—uterine cancer	8.03e-06	0.00122	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PGR—uterine cancer	7.93e-06	0.00121	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.82e-06	0.00119	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	7.71e-06	0.00117	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—AKT1—uterine cancer	7.67e-06	0.00117	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—INHBA—uterine cancer	7.63e-06	0.00116	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.56e-06	0.00115	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—EZH2—uterine cancer	7.53e-06	0.00115	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR1—uterine cancer	7.21e-06	0.0011	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STK11—uterine cancer	7.02e-06	0.00107	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ESR2—uterine cancer	6.98e-06	0.00106	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKR1C1—uterine cancer	6.87e-06	0.00105	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SOCS3—uterine cancer	6.58e-06	0.001	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.39e-06	0.000974	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN2B—uterine cancer	6.3e-06	0.00096	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IGF1R—uterine cancer	6.11e-06	0.000932	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SMAD3—uterine cancer	5.75e-06	0.000876	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—CDKN2B—uterine cancer	5.68e-06	0.000866	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGFR2—uterine cancer	5.48e-06	0.000836	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKR1C3—uterine cancer	5.29e-06	0.000807	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SMAD3—uterine cancer	5.19e-06	0.000791	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PGR—uterine cancer	5.16e-06	0.000786	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—YWHAE—uterine cancer	4.92e-06	0.00075	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FBXW7—uterine cancer	4.72e-06	0.000719	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ESR1—uterine cancer	4.69e-06	0.000715	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CCL2—uterine cancer	4.13e-06	0.00063	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STK11—uterine cancer	4.12e-06	0.000628	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SOCS3—uterine cancer	3.86e-06	0.000588	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN2B—uterine cancer	3.69e-06	0.000563	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IGF1R—uterine cancer	3.59e-06	0.000547	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB2—uterine cancer	3.44e-06	0.000525	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SMAD3—uterine cancer	3.37e-06	0.000514	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCL8—uterine cancer	3.26e-06	0.000498	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGFR2—uterine cancer	3.22e-06	0.000491	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1B—uterine cancer	3.19e-06	0.000486	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CTNNB1—uterine cancer	3.01e-06	0.000459	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTEN—uterine cancer	2.94e-06	0.000448	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EP300—uterine cancer	2.8e-06	0.000427	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—VEGFA—uterine cancer	2.65e-06	0.000404	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NRAS—uterine cancer	2.62e-06	0.000399	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—AKT1—uterine cancer	2.6e-06	0.000397	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCL2—uterine cancer	2.42e-06	0.000369	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KRAS—uterine cancer	2.25e-06	0.000344	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CA—uterine cancer	2.07e-06	0.000316	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB2—uterine cancer	2.02e-06	0.000308	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—uterine cancer	2e-06	0.000305	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL8—uterine cancer	1.92e-06	0.000292	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HRAS—uterine cancer	1.92e-06	0.000292	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1B—uterine cancer	1.87e-06	0.000285	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CTNNB1—uterine cancer	1.77e-06	0.00027	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTEN—uterine cancer	1.72e-06	0.000263	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKT1—uterine cancer	1.69e-06	0.000258	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EP300—uterine cancer	1.64e-06	0.000251	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VEGFA—uterine cancer	1.56e-06	0.000237	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NRAS—uterine cancer	1.54e-06	0.000234	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AKT1—uterine cancer	1.53e-06	0.000233	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KRAS—uterine cancer	1.32e-06	0.000202	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CA—uterine cancer	1.22e-06	0.000185	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—uterine cancer	1.18e-06	0.000179	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HRAS—uterine cancer	1.12e-06	0.000171	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKT1—uterine cancer	9.93e-07	0.000151	CbGpPWpGaD
